Related Experiment Video
Updated: Jul 28, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
Jaime A Soto1, María Isabel Méndez2, Jonathan D Berman3,4
11Fundación Nacional de Dermatologıa (FUNDERMA) y Hospital Dermatologico de Jorochito, Santa Cruz, Bolivia.
Abstract:
We present case reports of two patients treated with miltefosine for mucocutaneous leishmaniasis whose gastrointestinal symptoms were initially diagnosed as a drug reaction and only later recognized as due to COVID-19. Gastrointestinal symptoms of COVID-19 are unusual, whereas gastrointestinal adverse drug reactions are very common. These reports exemplify that this infrequent presentation of COVID-19 is likely to be ascribed to a more common etiology such as a gastrointestinal drug reaction.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Toxoplasmosis